In today's (29 July) quarterly report about, Atomo Diagnostics (AT1) mentioned ::- "We were pleased to see the successful listing of our strategic partner, Lumos Diagnostics in July, and remain hopeful that it will soon receive US FDA approval for its FebriDx diagnostic test, which utilises Atomo’s Pascal rapid test device."
AT1 is trading 11% higher today on contrary to LDX
- Forums
- ASX - By Stock
- LDX
- LDX Price Target $1.0
LDX Price Target $1.0, page-3
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $18.77M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 3.9¢ | $5.135K | 125.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 217592 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 42408 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 217592 | 0.039 |
2 | 254908 | 0.038 |
4 | 751001 | 0.037 |
4 | 204406 | 0.035 |
1 | 30303 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 42408 | 1 |
0.042 | 352408 | 3 |
0.043 | 270000 | 2 |
0.046 | 100000 | 1 |
0.047 | 90000 | 1 |
Last trade - 15.55pm 15/08/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online